Navigation Links
Patient Safety Technologies Reports Third Quarter 2011 Results
Date:11/15/2011

September 30, 2010, our year over year third quarter 2011 revenue growth was 38%.

Reported operating expenses for the third quarter of 2011 were $1.5 million as compared to $1.2 million during the third quarter of 2010.  Total non-GAAP cash expenses for the third quarter of 2011 were $1.2 million as compared to $1.3 million for the third quarter of 2010.

During the third quarter of 2011, the Company generated an Adjusted Operating Loss (as defined below) of $127 thousand and a GAAP operating loss of $529 thousand.  This compares with an Adjusted Operating Loss of $259 thousand for the third quarter of 2010 and GAAP operating income of $925 thousand.  

The Company ended the third quarter of 2011 with $5.0 million of cash and cash equivalents and no debt.  

Landmark Product Usage Milestones AchievedSubsequent to the end of the third quarter of 2011, use of the SurgiCount Safety-Sponge® System surpassed an estimated 60 million sponges successfully used in over 3 million procedures."During the third quarter we were successful in continuing to grow our installed base of current users, significantly expanding the number of incremental facilities under contract with future expected implementations and maintaining our reduced cost structure.  We expect to see the positive impact on our revenues and profitability as we implement these additional facilities over the coming months.  Further, as our user base and the evidence of the clinical efficacy of the Safety-Sponge® System continues to grow, we are well positioned to be the solution of choice for the growing number of hospitals looking to address the common yet preventable surgical mistake of retained surgical sponges," stated Brian E. Stewart, President and Chief Executive Officer of Patient Safety Technologies, Inc.

The Company's third quarter 2011 financial statements are included in its Quarterly Report on Form 10-Q filed by
'/>"/>

SOURCE Patient Safety Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
7. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
8. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. Many Heart Attack Patients Dont Get Best Emergency Treatment
11. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)...  Perrigo Company plc ("Perrigo") (NYSE: PRGO ... Healthcare Products®," today announced the closing of Perrigo,s previously ... 6,809,210 ordinary shares at a public offering price of ... option to purchase up to an additional 888,157 ordinary ... Inc., as representatives of the several underwriters. ...
(Date:11/26/2014)... Nov. 26, 2014   Regulus Therapeutics Inc . ... the discovery and development of innovative medicines targeting microRNAs, ... President and CEO of Regulus, will present a company ... Healthcare Conference at the New York Palace Hotel on ... presentation will be webcast at the time of the ...
(Date:11/26/2014)... LOUIS , Nov. 26, 2014 Scott Steiger ... seen most of the world. As an engineer for the past ... a member of the military service. He,s been to six of ... Photo - http://photos.prnewswire.com/prnh/20141126/161076 Photo - ... specifically for travelers, he has a pretty good idea of what,s ...
Breaking Medicine Technology:Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 2Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 3Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 4Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 2Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 3Steiger Has Created the First Pill Case Specifically Designed For Travel 2
... National Community Pharmacists Association Executive Vice ... in response to the Florida House Judicial Committee,s passage of ... in particular an amendment that would restrict the ... III to publicly traded pharmacy chains or only those ...
... 31, 2011 OncoSec Medical Inc. (OTC BB: ONCS), a ... announced today that it has raised more than $1 million ... institutional investors. OncoSec issued 1,456,000 units at a price of ... consisted of one share of common stock and one share ...
Cached Medicine Technology:Legislation Would Deny Floridians Access to Needed Medicines from Their Trusted Independent Community Pharmacies, and Instead Favor Publicly Traded Chain Pharmacies 2OncoSec Medical Closes $1.1M Financing 2
(Date:11/26/2014)... Recently, Locks-Magnetic.com, a Chinese outstanding Maglocks supplier, is ... on the Internet. It also provides a big discount ... As a leading company in the electronic lock industry, ... buy high quality locks. It can meet the demands ... are not only useful but also affordable. However, inexpensive ...
(Date:11/26/2014)... Boxing Day is traditionally the day ... gifts, known as a "Christmas box", from their bosses ... the coming of Boxing Day, some people may worry ... every business opportunity, and it has recently announced its ... promotion for its global customers. Then people can buy ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 Pharmaceutical ... humidity, and pressure levels during manufacturing and research ... and air conditioning) systems play a key role. ... microorganisms or bio-contaminants, while humidity can affect the ... The use of HVAC systems helps to address ...
(Date:11/26/2014)... Dallas, Texas (PRWEB) November 26, 2014 ... surgeon and Distinguished Teaching Professor in the ... Center, recently discussed facial fat compartments, fat grafting, ... Surgery, The Meeting," an annual conference held by ... importance and intricacies of this underlying facial structure ...
(Date:11/26/2014)... HealthDay Reporter WEDNESDAY, Nov. 26, ... more likely to achieve remission if they maintain a healthy ... that those who were heaviest had almost 65 percent reduced ... of remission. "Medication for rheumatoid arthritis is not as ... study,s lead author and a rheumatologist at the Hospital for ...
Breaking Medicine News(10 mins):Health News:Fresh Products Launched by Famous Company Lock-Magnetic.com 2Health News:Tbdress.com: Best Boxing Day Sales For Ladies Worldwide 2Health News:Cleanroom Technology Market to Hit $3,761.9 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Cleanroom Technology Market to Hit $3,761.9 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Cleanroom Technology Market to Hit $3,761.9 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:Cleanroom Technology Market to Hit $3,761.9 Million by 2019 - New Research Report by MarketsandMarkets 5Health News:Dr. Rod J. Rohrich Discusses Facelifts at ASPS Annual Assembly 2Health News:Dr. Rod J. Rohrich Discusses Facelifts at ASPS Annual Assembly 3Health News:Weight Could Influence Rheumatoid Arthritis Relief 2Health News:Weight Could Influence Rheumatoid Arthritis Relief 3
... have an increased risk of heart disease and death. ... older women who participated in the Women's Health Initiative ... designed to determine how biological and lifestyle factors influence ... health conditions. For this study, participants were evaluated for ...
... help protect the eyes against a leading cause of age-related ... // men and women it was found that those who ... a 36-percent lower risk of developing age-related maculopathy than those ... linked consumption of antioxidant vitamins and minerals to lower rates ...
... characterized by severe impairment in the ability to socialize ... the // condition are diagnosed around the age ... normal social and communication skills. ,Several studies have ... the disease has a genetic basis. Others have suggested ...
... combination treatment proves to be the best option to substantially ... to remove part of the affected vein in addition to ... leg ulcers .Surgery did not present any additional benefit in ... reduced from 28 percent to 14 percent at one year. ...
... be a relationship between the state of cancer patients’ ... treatment.// ,For the study researchers evaluated quality ... colorectal cancer. Before patients ever received chemotherapy, quality of ... treated with a new regimen that involves common side ...
... across the world especially when the pollen count is high ... 50 million people every year. In almost 38 million people, ... like chronic sinus infections. Newer treatments are now availble to ... a ENT and Head and Neck Surgeon at , of ...
Cached Medicine News:
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
20 GA TITANIUM RETINAL FORCEPS...
... German Craftsmanship have produced ... in the world. Ocutek ... to you! Only holders ... certificate, which requires and ...
Medicine Products: